Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SURBHI SIDANA

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1972868644
CMS profile
1328365
Location
STANFORD, CA

General Payments · PY2019–2024

$108,165.22

  • Reported across 127 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$41,873.07

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $14,942.94 15
Janssen Global Services, LLC $7,317.64 10
Kite Pharma, Inc. $4,120.00 3
F. Hoffmann-La Roche AG $3,148.24 3
E.R. Squibb & Sons, L.L.C. $2,691.61 5
Gilead Sciences, Inc. $2,540.00 1
ABBVIE INC. $2,200.00 1
BioLineRx USA, Inc. $1,562.50 1
Janssen Scientific Affairs, LLC $1,090.00 1
PFIZER INC. $782.98 3
Genentech USA, Inc. $625.00 1
Celgene Corporation $596.20 5
Janssen Biotech, Inc. $130.28 2
Genentech, Inc. $125.68 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,327.32 7
PY2020 $2,640.00 1
PY2021 $6,030.50 3
PY2022 $17,167.58 20
PY2023 $38,126.75 44
PY2024 $41,873.07 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $2,200.00 02/19/2024 Consulting Fee Undisputed 01/23/2026 1106096699 CMS
BioLineRx USA, Inc. $1,562.50 12/26/2024 Consulting Fee Undisputed 01/23/2026 1145040015 CMS
Celgene Corporation $378.24 02/20/2024 Food and Beverage Undisputed 01/23/2026 1101119961 CMS
Celgene Corporation $124.88 04/03/2024 Food and Beverage Undisputed 01/23/2026 1101119943 CMS
Celgene Corporation $37.54 06/03/2024 Food and Beverage Undisputed 01/23/2026 1101119949 CMS
Celgene Corporation $27.77 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101119963 CMS
Celgene Corporation $27.77 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101119965 CMS
E.R. Squibb & Sons, L.L.C. $2,249.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1101366906 CMS
E.R. Squibb & Sons, L.L.C. $355.15 02/20/2024 Travel and Lodging Undisputed 01/23/2026 1101366948 CMS
E.R. Squibb & Sons, L.L.C. $23.09 02/20/2024 Travel and Lodging Undisputed 01/23/2026 1101366950 CMS
E.R. Squibb & Sons, L.L.C. $10.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1101366960 CMS
E.R. Squibb & Sons, L.L.C. $54.37 06/06/2024 Food and Beverage Undisputed 01/23/2026 1101366968 CMS
F. Hoffmann-La Roche AG $3,040.00 06/13/2024 Consulting Fee Undisputed 01/23/2026 1133119610 CMS
F. Hoffmann-La Roche AG $53.61 06/13/2024 Travel and Lodging Undisputed 01/23/2026 1133119614 CMS
F. Hoffmann-La Roche AG $54.63 06/13/2024 Food and Beverage Undisputed 01/23/2026 1133119618 CMS
Genentech USA, Inc. $625.00 10/07/2024 Consulting Fee Undisputed 01/23/2026 1133119626 CMS
Genentech, Inc. $125.68 09/03/2024 Food and Beverage Undisputed 01/23/2026 1133119622 CMS
Gilead Sciences, Inc. $2,540.00 12/16/2024 Consulting Fee Undisputed 01/23/2026 1133599223 CMS
Janssen Biotech, Inc. $62.99 09/25/2024 Food and Beverage Undisputed 01/23/2026 1078342579 CMS
Janssen Biotech, Inc. $67.29 12/07/2024 Food and Beverage Undisputed 01/23/2026 1078342322 CMS
Janssen Global Services, LLC $31.51 06/13/2024 Travel and Lodging Undisputed 01/23/2026 1077590613 CMS
Janssen Global Services, LLC $32.20 06/13/2024 Travel and Lodging Undisputed 01/23/2026 1077590625 CMS
Janssen Global Services, LLC $2,362.50 06/28/2024 Consulting Fee Undisputed 01/23/2026 1077590629 CMS
Janssen Global Services, LLC $55.17 09/23/2024 Food and Beverage Undisputed 01/23/2026 1077590617 CMS
Janssen Global Services, LLC $56.78 09/24/2024 Food and Beverage Undisputed 01/23/2026 1077590607 CMS
Janssen Global Services, LLC $12.55 09/24/2024 Food and Beverage Undisputed 01/23/2026 1077590639 CMS
Janssen Global Services, LLC $675.00 10/04/2024 Consulting Fee Undisputed 01/23/2026 1077590609 CMS
Janssen Global Services, LLC $2,700.00 10/11/2024 Consulting Fee Undisputed 01/23/2026 1077590621 CMS
Janssen Global Services, LLC $1,350.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 1077590627 CMS
Janssen Global Services, LLC $41.93 12/06/2024 Food and Beverage Undisputed 01/23/2026 1077590619 CMS
Janssen Scientific Affairs, LLC $1,090.00 11/19/2024 Consulting Fee Undisputed 01/23/2026 1078845947 CMS
Kite Pharma, Inc. $50.00 03/22/2024 Food and Beverage Undisputed 01/23/2026 1128612715 CMS
Kite Pharma, Inc. $50.00 03/22/2024 Food and Beverage Undisputed 01/23/2026 1128612717 CMS
Kite Pharma, Inc. $4,020.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 1128612707 CMS
PFIZER INC. $630.00 01/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131563051 CMS
PFIZER INC. $50.52 09/25/2024 Food and Beverage Undisputed 01/23/2026 1131620135 CMS
PFIZER INC. $102.46 09/27/2024 Food and Beverage Undisputed 01/23/2026 1131997043 CMS
Regeneron Pharmaceuticals, Inc. $4,572.86 05/30/2024 Travel and Lodging Undisputed 01/23/2026 1114405163 CMS
Regeneron Pharmaceuticals, Inc. $35.25 05/30/2024 Travel and Lodging Undisputed 01/23/2026 1114405165 CMS
Regeneron Pharmaceuticals, Inc. $154.82 06/21/2024 Travel and Lodging Undisputed 01/23/2026 1114405167 CMS
Regeneron Pharmaceuticals, Inc. $150.00 06/24/2024 Travel and Lodging Undisputed 01/23/2026 1114405169 CMS
Regeneron Pharmaceuticals, Inc. $91.93 08/06/2024 Food and Beverage Undisputed 01/23/2026 1114405171 CMS
Regeneron Pharmaceuticals, Inc. $95.47 08/06/2024 Food and Beverage Undisputed 01/23/2026 1114405173 CMS
Regeneron Pharmaceuticals, Inc. $142.01 08/06/2024 Food and Beverage Undisputed 01/23/2026 1114405175 CMS
Regeneron Pharmaceuticals, Inc. $346.61 08/06/2024 Travel and Lodging Undisputed 01/23/2026 1114405177 CMS
Regeneron Pharmaceuticals, Inc. $4,155.00 08/23/2024 Consulting Fee Undisputed 01/23/2026 1114405179 CMS
Regeneron Pharmaceuticals, Inc. $4,986.00 08/23/2024 Consulting Fee Undisputed 01/23/2026 1114405181 CMS
Regeneron Pharmaceuticals, Inc. $77.69 08/23/2024 Travel and Lodging Undisputed 01/23/2026 1114405183 CMS
Regeneron Pharmaceuticals, Inc. $97.44 08/23/2024 Travel and Lodging Undisputed 01/23/2026 1114405185 CMS
Regeneron Pharmaceuticals, Inc. $21.86 08/23/2024 Food and Beverage Undisputed 01/23/2026 1114405187 CMS
Regeneron Pharmaceuticals, Inc. $8.00 08/23/2024 Travel and Lodging Undisputed 01/23/2026 1114405189 CMS
Regeneron Pharmaceuticals, Inc. $8.00 08/23/2024 Travel and Lodging Undisputed 01/23/2026 1114405191 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.